Low-grade gliomas in adults
- PMID: 16794247
- DOI: 10.1634/theoncologist.11-6-681
Low-grade gliomas in adults
Abstract
Low-grade gliomas are a heterogeneous group of neoplasms usually encountered in younger patient populations. These tumors represent a unique challenge because most patients will survive a decade or more and may be at a higher risk for treatment-related complications. Clinical observations over the years have identified a subset of low-grade gliomas that tends to manifest more aggressive clinical behavior and require earlier, more aggressive intervention. Clinical and molecular parameters may allow better assessment of prognosis and application of risk-adjusted management strategies that may include resection, radiation, or chemotherapy. Improved methods of long-term cognitive and functional assessment are desperately needed in this patient population.
Similar articles
-
[Risk of increased malignancy a reason for follow-up of low malignancy grade glioma. Early identification of high-risk patients is the key to good care].Lakartidningen. 2000 Sep 6;97(36):3886-90. Lakartidningen. 2000. PMID: 11036339 Review. Swedish.
-
Pediatric high-grade gliomas and diffuse intrinsic pontine gliomas.J Child Neurol. 2009 Nov;24(11):1409-17. doi: 10.1177/0883073809338960. Epub 2009 Jul 28. J Child Neurol. 2009. PMID: 19638636 Review.
-
Outcome in adult low-grade glioma: the impact of prognostic factors and treatment.Neurology. 2007 Sep 25;69(13):1366-73. doi: 10.1212/01.wnl.0000277271.47601.a1. Neurology. 2007. PMID: 17893297 Review.
-
Low-grade glial tumors: are they all the same?Semin Pediatr Neurol. 2009 Mar;16(1):23-6. doi: 10.1016/j.spen.2009.03.002. Semin Pediatr Neurol. 2009. PMID: 19410153 Review.
-
Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.Br J Neurosurg. 2009 Aug;23(4):351-63. doi: 10.1080/02688690903158809. Br J Neurosurg. 2009. PMID: 19637006 Review.
Cited by
-
Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas: preliminary results of Radiation Therapy Oncology Group 0424.Int J Radiat Oncol Biol Phys. 2015 Mar 1;91(3):497-504. doi: 10.1016/j.ijrobp.2014.11.012. Epub 2015 Jan 30. Int J Radiat Oncol Biol Phys. 2015. PMID: 25680596 Free PMC article. Clinical Trial.
-
Histogram analysis of MR imaging-derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes.AJNR Am J Neuroradiol. 2008 Oct;29(9):1664-70. doi: 10.3174/ajnr.A1182. Epub 2008 Jun 26. AJNR Am J Neuroradiol. 2008. PMID: 18583405 Free PMC article.
-
G6PD as a predictive marker for glioma risk, prognosis and chemosensitivity.J Neurooncol. 2018 Sep;139(3):661-670. doi: 10.1007/s11060-018-2911-8. Epub 2018 May 29. J Neurooncol. 2018. PMID: 29845423
-
Differentiating between Glioblastoma and Primary CNS Lymphoma Using Combined Whole-tumor Histogram Analysis of the Normalized Cerebral Blood Volume and the Apparent Diffusion Coefficient.Magn Reson Med Sci. 2019 Jan 10;18(1):53-61. doi: 10.2463/mrms.mp.2017-0135. Epub 2018 May 31. Magn Reson Med Sci. 2019. PMID: 29848919 Free PMC article.
-
Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas.Oncotarget. 2014 Sep 30;5(18):8083-92. doi: 10.18632/oncotarget.2342. Oncotarget. 2014. PMID: 25257301 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical